Application of Lung Ultrasound During the COVID-19 Pandemic: A Narrative Review

This review highlights the ultrasound findings reported from a number of studies and case reports and discusses the unifying findings from coronavirus disease (COVID-19) patients and from the avian (H7N9) and H1N1 influenza epidemics. We discuss the potential role for portable point-of-care ultrasou...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Anesthesia and analgesia 2020-08, Vol.131 (2), p.345-350
Hauptverfasser:	Convissar, David L., Gibson, Lauren E., Berra, Lorenzo, Bittner, Edward A., Chang, Marvin G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Betacoronavirus - pathogenicity Coronavirus Infections - diagnostic imaging Coronavirus Infections - therapy Coronavirus Infections - transmission Coronavirus Infections - virology COVID-19 Female Humans Infection Control Infectious Disease Transmission, Patient-to-Professional - prevention & control Influenza A Virus, H1N1 Subtype - pathogenicity Influenza A Virus, H7N9 Subtype - pathogenicity Influenza, Human - diagnostic imaging Influenza, Human - virology Lung - diagnostic imaging Lung - virology Male Middle Aged Occupational Exposure - adverse effects Occupational Exposure - prevention & control Pandemics Pneumonia, Viral - diagnostic imaging Pneumonia, Viral - therapy Pneumonia, Viral - transmission Pneumonia, Viral - virology Point-of-Care Systems Point-of-Care Testing Predictive Value of Tests Prognosis Risk Factors SARS-CoV-2 Ultrasonography - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This review highlights the ultrasound findings reported from a number of studies and case reports and discusses the unifying findings from coronavirus disease (COVID-19) patients and from the avian (H7N9) and H1N1 influenza epidemics. We discuss the potential role for portable point-of-care ultrasound (PPOCUS) as a safe and effective bedside option in the initial evaluation, management, and monitoring of disease progression in patients with confirmed or suspected COVID-19 infection.
ISSN:	0003-2999 1526-7598
DOI:	10.1213/ANE.0000000000004929